초록 ▼

A safety buckle assembly including a male member and a female member that interlockingly and releasably engages the male member. The buckle male member is disengaged from the female member by squeezing the side latches towards each other, to disengage the same from the side catches, while simultaneo

A safety buckle assembly including a male member and a female member that interlockingly and releasably engages the male member. The buckle male member is disengaged from the female member by squeezing the side latches towards each other, to disengage the same from the side catches, while simultaneously pressing the push release button such that the central latch is disengaged from the central catch formed in the female member.

대표청구항 ▼

A safety buckle assembly including a male member and a female member that interlockingly and releasably engages the male member. The buckle male member is disengaged from the female member by squeezing the side latches towards each other, to disengage the same from the side catches, while simultaneo

A safety buckle assembly including a male member and a female member that interlockingly and releasably engages the male member. The buckle male member is disengaged from the female member by squeezing the side latches towards each other, to disengage the same from the side catches, while simultaneously pressing the push release button such that the central latch is disengaged from the central catch formed in the female member. tion to said candidate abnormality to derive cross-correlation values between the candidate abnormality and each of the shifted first and second templates. 4. The method of claim 3, wherein said step of obtaining comprises: obtaining candidate first templates and candidate second templates; comparing the candidate first templates to at least one known non-abnormality structure and retaining as first templates only those candidate first templates which exhibit a predetermined degree of non-similarity to the at least one known non-abnormality structure; and comparing the candidate second templates to at least one known abnormality structure and retaining as second templates only those candidate second templates which exhibit a predetermined degree of non-similarity to the at least one known abnormality structure. 5. The method of claim 3, further comprising: obtaining at least one third template and at least one fourth template respectively corresponding to predetermined malignant and predetermined benign abnormalities; comparing an actual abnormality with the obtained third and fourth templates to determined a degree of matching between the actual abnormality and each of the obtained third and fourth templates; and classifying the actual abnormality as a malignant abnormality or a non-malignant abnormality based on whether a best match is obtained by comparing the actual abnormality with the at least one third template or the at least one fourth template. 6. The method of claim 2, wherein said step of obtaining comprises: obtaining candidate first templates and candidate second templates; comparing the candidate first templates to at least one known non-abnormality structure and retaining as first templates only those candidate first templates which exhibit a predetermined degree of non-similarity to the at least one known non-abnormality structure; and comparing the candidate second templates to at least one known abnormality structure and retaining as second templates only those candidate second templates which exhibit a predetermined degree of non-similarity to the at least one known abnormality structure. 7. The method of claim 2, further comprising: obtaining at least one third template and at least one fourth template respectively corresponding to predetermined malignant and predetermined benign abnormalities; comparing an actual abnormality with the obtained third and fourth templates to determine a degree of matching between the actual abnormality and each of the obtained third and fourth templates; and classifying the actual abnormality as a malignant abnormality or a non-malignant abnormality based on whether a best match is obtained by comparing the actual abnormality with the at least one third template or the at least one fourth template. 8. The method of claim 2, wherein said step of obtaining comprises: obtaining candidate first templates and candidate second templates; comparing the candidate first templates to at least one known benign structure and retaining as first templates only those candidate first templates which exhibit a predetermined degree of non-similarity to the at least one known benign structure; and comparing the candidate second templates to at least one known malignant structure and retaining as second templates only those candidate second templates which exhibit a predetermined degree of non-similarity to the at least one known malignant structure. 9. The method of claim 1, wherein said step of obtaining comprises: produc